Clinical Research Pathways Inc

CLINICAL RESEARCH PATHWAYS WORKS TO IMPROVE HEALTH AND WELL-BEING FOR ALL BY CREATING PATHWAYS TO NEW MEDICINES.

CLINICAL RESEARCH PATHWAYS HAS INTRODUCED AN INNOVATIVE PROGRAM, TRAINING MINORITY CLINICAL TEAMS: GETTING NEW QUALITY MEDICINE TO ALL AMERICANS, TO ENCOURAGE MINORITIES TO PARTICIPATE IN APPROPRIATE CLINICAL TRIALS. ENROLLMENT IS HANDLED AT THE POINT OF CARE BY HEALTHCARE PROVIDERS WHO HAVE EARNED PATIENTS' TRUST AND HAVE RECEIVED TRAINING AND MENTORING AS CLINICAL INVESTIGATORS. CLINICAL RESEARCH PATHWAYS LAUNCHED THE PROGRAM BY AWARDING A THREE-YEAR GRANT TO MOREHOUSE SCHOOL OF MEDICINE IN GEORGIA, WHERE 31.7% OF THE POPULATION IS AFRICAN AMERICAN AND 9.4% IS LATINO. FOR THE FIRST YEAR, THE PROGRAM WILL CONCENTRATE ON CARDIOVASCULAR DISEASE. THE LEADING CAUSE OF DEATH WORLDWIDE, CARDIOVASCULAR DISEASE PRESENTS EVEN HIGHER RISK FOR AFRICAN AMERICANS AND LATINOS. THEREFORE, THE INITIAL RECRUITMENT, TRAINING, AND MENTORING EFFORTS WILL TARGET PRIMARY CARE PHYSICIANS AND CARDIOLOGISTS. IN SUBSEQUENT YEARS, THE PROJECT WILL BE EXPANDED TO INCLUDE OTHER SIGNIFICANT TREATMENT AREAS, SUCH AS CANCER, ARTHRITIS, AND NEUROBIOLOGY.

CLINICAL RESEARCH PATHWAYS HELPS PHYSICIANS AND DESPERATELY ILL PATIENTS WITH THE APPROVAL PROCESS FOR EXPERIMENTAL MEDICINES UNDER FDA'S EXPANDED ACCESS PROGRAM. WE HELP SIMPLIFY THE APPROVAL PROCESS FOR DESPERATELY-ILL PATIENTS BY PROVIDING EDUCATIONAL MATERIALS AND TRAINING TO PHYSICIANS AND INSTITUTIONAL REVIEW BOARDS (IRBS). WE PROVIDE WEBINARS AND ORIGINAL STEP-BY-STEP GUIDES PROVIDE EASY-TO-UNDERSTAND INFORMATION ON EXPANDED ACCESS TOPICS, INCLUDING: 1) FOR PATIENTS - POINTS TO CONSIDER ABOUT CLINICAL TRIALS AND EXPANDED ACCESS 2) FOR ANYONE INTERESTED IN EXPANDED ACCESS - MAKING SENSE OF THE NEW RIGHT-TO-TRY LAW 3) FOR PHYSICIANS - HOW TO APPLY FOR EXPANDED ACCESS FOR INDIVIDUAL PATIENTS AND GROUPS OF PATIENTS 4) FOR IRBS - HOW TO STREAMLINE THE APPROVAL PROCESS